JP2024525141A - ポリアミン基およびポリアルキレンオキシド基を有する側鎖を含む生分解性ポリマー - Google Patents

ポリアミン基およびポリアルキレンオキシド基を有する側鎖を含む生分解性ポリマー Download PDF

Info

Publication number
JP2024525141A
JP2024525141A JP2023575995A JP2023575995A JP2024525141A JP 2024525141 A JP2024525141 A JP 2024525141A JP 2023575995 A JP2023575995 A JP 2023575995A JP 2023575995 A JP2023575995 A JP 2023575995A JP 2024525141 A JP2024525141 A JP 2024525141A
Authority
JP
Japan
Prior art keywords
group
polymer
r1nh
independently
integer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023575995A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024525141A5 (cg-RX-API-DMAC10.html
Inventor
リー、クンウー
マイティー、サンタヌ
デヴュラパリー、ラモハン
パトリック ミード、ブライアン
ティルチナパリー、ゴピナート
マリー ペイロ、サラ
Original Assignee
ジーンエディット インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジーンエディット インコーポレイテッド filed Critical ジーンエディット インコーポレイテッド
Publication of JP2024525141A publication Critical patent/JP2024525141A/ja
Publication of JP2024525141A5 publication Critical patent/JP2024525141A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595—Polyamides, e.g. nylon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A61K48/0041—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being polymeric
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10—Alpha-amino-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/48—Polymers modified by chemical after-treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Polyethers (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Polyamides (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2023575995A 2021-06-11 2022-06-13 ポリアミン基およびポリアルキレンオキシド基を有する側鎖を含む生分解性ポリマー Pending JP2024525141A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163209919P 2021-06-11 2021-06-11
US63/209,919 2021-06-11
PCT/US2022/033302 WO2022261561A1 (en) 2021-06-11 2022-06-13 Biodegradable polymer comprising side chains with polyamine and polyalkylene oxide groups

Publications (2)

Publication Number Publication Date
JP2024525141A true JP2024525141A (ja) 2024-07-10
JP2024525141A5 JP2024525141A5 (cg-RX-API-DMAC10.html) 2025-06-20

Family

ID=82703024

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023575995A Pending JP2024525141A (ja) 2021-06-11 2022-06-13 ポリアミン基およびポリアルキレンオキシド基を有する側鎖を含む生分解性ポリマー

Country Status (5)

Country Link
US (1) US20240285781A1 (cg-RX-API-DMAC10.html)
EP (1) EP4352131A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024525141A (cg-RX-API-DMAC10.html)
CA (1) CA3222341A1 (cg-RX-API-DMAC10.html)
WO (1) WO2022261561A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121136065A (zh) 2018-04-27 2025-12-16 基因编辑有限公司 阳离子聚合物和用于生物分子递送的用途
EP3856759A4 (en) 2018-09-25 2022-10-12 The University of Tokyo AMPHIPHILIC POLY(AMINO ACID), BLOCK COPOLYMER USING THE AMPHIPHIL POLYAMINO ACID AND COMPLEX WITH THE AMPHIPHILIC POLY(AMINO ACID) OR THE BLOCK COPOLYMER AND NUCLEIC ACID

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011173802A (ja) * 2010-02-23 2011-09-08 Nano Career Kk 短鎖のカチオン性ポリアミノ酸およびその使用
WO2019210326A2 (en) * 2018-04-27 2019-10-31 Genedit Inc. Cationic polymer and use for biomolecule delivery
WO2020243370A1 (en) * 2019-05-28 2020-12-03 Genedit Inc. Polymer comprising multiple functionalized sidechains for biomolecule delivery
CN114007597A (zh) * 2019-04-23 2022-02-01 基因编辑有限公司 具有烷基侧链的阳离子聚合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010075303A1 (en) 2008-12-23 2010-07-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Splicing factors with a puf protein rna-binding domain and a splicing effector domain and uses of same
US9580714B2 (en) 2010-11-24 2017-02-28 The University Of Western Australia Peptides for the specific binding of RNA targets
WO2013155555A1 (en) 2012-04-16 2013-10-24 The University Of Western Australia Peptides for the binding of nucleotide targets
WO2014093694A1 (en) 2012-12-12 2014-06-19 The Broad Institute, Inc. Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes
CN105209621B (zh) 2012-12-12 2021-05-25 布罗德研究所有限公司 对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化
KR102955556B1 (ko) 2012-12-12 2026-04-22 더 브로드 인스티튜트, 인코퍼레이티드 서열 조작을 위한 crispr-cas 성분 시스템, 방법 및 조성물
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
MX380562B (es) 2012-12-12 2025-03-12 Broad Inst Inc Modificaciones de sistemas, métodos y composiciones guía optimizadas para la manipulación de secuencias.
PT2931898E (pt) 2012-12-12 2016-06-16 Harvard College Manipulação e otimização de sistemas, métodos e composições para manipulação de sequências com domínios funcionais
WO2020086910A1 (en) 2018-10-24 2020-04-30 Genedit Inc. Cationic polymer with alkyl side chains and use for biomolecule delivery
WO2021217082A1 (en) 2020-04-23 2021-10-28 Genedit Inc. Polymer with cationic and hydrophobic side chains

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011173802A (ja) * 2010-02-23 2011-09-08 Nano Career Kk 短鎖のカチオン性ポリアミノ酸およびその使用
US20120149649A1 (en) * 2010-02-23 2012-06-14 The University Of Tokyo Short-chain cationic polyamino acid and use thereof
WO2019210326A2 (en) * 2018-04-27 2019-10-31 Genedit Inc. Cationic polymer and use for biomolecule delivery
CN112334510A (zh) * 2018-04-27 2021-02-05 基因编辑有限公司 阳离子聚合物和用于生物分子递送的用途
JP2021522385A (ja) * 2018-04-27 2021-08-30 ジーンエディット インコーポレイテッド カチオン性ポリマーおよびその生体分子送達のための使用
CN114007597A (zh) * 2019-04-23 2022-02-01 基因编辑有限公司 具有烷基侧链的阳离子聚合物
US20220340711A1 (en) * 2019-04-23 2022-10-27 GenEdit, Inc. Cationic polymer with alkyl side chains
WO2020243370A1 (en) * 2019-05-28 2020-12-03 Genedit Inc. Polymer comprising multiple functionalized sidechains for biomolecule delivery
JP2022534245A (ja) * 2019-05-28 2022-07-28 ジーンエディット インコーポレイテッド 生体分子送達のための複数の機能化側鎖を含むポリマー

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LIU, CHANGXING ET AL: "Novel biodegradable lipid nano complex for siRNA deliverysignificantly improving the chemosensitivit", JOURNALOF CONTROLLED RELEASE, vol. 140, JPN6026017868, 2009, pages 277 - 283, ISSN: 0005856225 *

Also Published As

Publication number Publication date
WO2022261561A1 (en) 2022-12-15
CA3222341A1 (en) 2022-12-15
US20240285781A1 (en) 2024-08-29
EP4352131A1 (en) 2024-04-17

Similar Documents

Publication Publication Date Title
JP7568511B2 (ja) カチオン性ポリマーおよびその生体分子送達のための使用
AU2020263474B2 (en) Cationic polymer with alkyl side chains
EP3870628B1 (en) Cationic polymer with alkyl side chains and use for biomolecule delivery
JP7805789B2 (ja) 生体分子送達のための複数の機能化側鎖を含むポリマー
US20230147779A1 (en) Polymer with cationic and hydrophobic side chains
KR20210039983A (ko) 게놈 편집을 위한 방법 및 조성물
US20240285781A1 (en) Biodegradable polymer comprising side chains with polyamine and polyalkylene oxide groups
HK40048202A (en) Cationic polymer with alkyl side chains and use for biomolecule delivery
HK40048202B (en) Cationic polymer with alkyl side chains and use for biomolecule delivery

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20240229

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20240229

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250612

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250612

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260409

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260512

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260728